Tazidime and Hypothermia - a phase IV clinical study of FDA data

Summary:

Hypothermia is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Vancomycin, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Hypothermia when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Hypothermia?

Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions) is found to be associated with 774 drugs and 997 conditions by eHealthMe. Check the latest studies of Hypothermia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 24 people (0.23%) have Hypothermia.

Among these 24 people:

How long have people been on Tazidime when they have Hypothermia? *

What is the gender of people who have Hypothermia when taking Tazidime? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Hypothermia when taking Tazidime? *

What are other drugs people take besides Tazidime? *

What are other side effects people have besides Hypothermia? *

Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 25.00%
Hypernatraemia (an abnormally high plasma concentration of sodium ions): 5 people, 20.83%
Rash Papular (redness with papule): 5 people, 20.83%
Weakness: 5 people, 20.83%
Arrhythmias (irregular heartbeat): 5 people, 20.83%
Thrombocytopenia (decrease of platelets in blood): 5 people, 20.83%
Dehydration (dryness resulting from the removal of water): 5 people, 20.83%
Enterococcal Sepsis: 5 people, 20.83%
Skin Exfoliation (removal of the oldest dead skin cells): 5 people, 20.83%
Fatigue (feeling of tiredness): 5 people, 20.83%

What are the existing conditions these people have? *

Systemic Candida (whole body fungal infection): 2 people, 8.33%
Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 8.33%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 8.33%
Bone Marrow Conditioning Regimen: 2 people, 8.33%
Rhabdoid Tumor Of The Kidney: 1 person, 4.17%
Infection: 1 person, 4.17%
Fever: 1 person, 4.17%
Diabetes: 1 person, 4.17%
Clostridium Test Positive: 1 person, 4.17%
Aspergillosis (an infection caused by a fungus called aspergillus): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Hypothermia?

- Check whether Hypothermia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Hypothermia treatments and more:

Hypothermia (12,298 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypothermia:

Hypothermia (774 drugs)

Browse all the conditions that are associated with Hypothermia:

Hypothermia (997 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.